Showing results (181-190 of 3,633) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|August 29, 2021
Underutilisation of breast cancer prevention medication in AustraliaCourtney Macdonald, James A Chamberlain, Danielle Mazza, et al.Breast (Edinburgh, Scotland)|September 6, 2021
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI studyVolkmar Müller, Markus Ruhnke, Oliver Hoffmann, et al.Breast (Edinburgh, Scotland)|August 15, 2022
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancerA Viansone, B Pellegrino, C Omarini, et al.Breast (Edinburgh, Scotland)|May 15, 2021
Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: A systematic review and meta-analysisFrancesco Garzotto, Rosanna Irene Comoretto, Silvia Michieletto, et al.Breast (Edinburgh, Scotland)|August 23, 2022
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY studyGiulia Mentrasti, Luca Cantini, Patrizia Vici, et al.Breast (Edinburgh, Scotland)|June 17, 2020
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)Laura Orlando, Vito Lorusso, Francesco Giotta, et al.Breast (Edinburgh, Scotland)|May 16, 2015
Evaluation of effect of self-examination and physical examination on breast cancerLotfi Mohammad Hassan, Noori Mahmoud, Anthony B Miller, et al.Breast (Edinburgh, Scotland)|May 4, 2020
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practiceNathalie I Bouwer, Agnes Jager, Crista Liesting, et al.Breast (Edinburgh, Scotland)|September 18, 2021
Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancerYaping Yang, Junwei Li, Yajing Liu, et al.Breast (Edinburgh, Scotland)|August 18, 2021
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysisNadia Bianco, Antonella Palazzo, Eleonora Pagan, et al.Pageof 364